Journals / İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2020 / Cilt: 24 - Sayı: 2

VITAMIN D, PARATHORMONE, GENDER, INTERLEUKIN 10 AND TUMOR NECROSIS ALPHA RELATIONSHIP IN MULTIPLE SCLEROSIS PATIENTS

MULTİPL SKLEROZ HASTALARINDA VİTAMİN D, PARATHORMON, CİNSİYET, İNTERLÖKİN 10 VE TÜMÖR NEKROZ FAKTÖR ALFA İLİŞKİSİ

Pages
121–126
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was no correlation betweenvitamin D levels and clinical features.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Vitamin D is thought to have a role on multiple sclerosis hence MS cases are less frequent in theareas where exposure to sunlight is high.
📊
Key Findings & Data:Materials and Methods: 74 patients with relapsing-remitting multiple sclerosis who were in the remission periodwere included in the study.
💡
Conclusion & Impact:There was no correlation betweenvitamin D levels and clinical features.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Vitamin D is thought to have a role on multiple sclerosis hence MS cases are less frequent in theareas where exposure to sunlight is high. The idea that vitamin D is related to clinical features and this effect ismore prominent in female patients is controversial. In this study, the relationship between vitamin D levels, proand anti-inflammatory cytokine levels and gender in relapsing-remitting multiple sclerosis patients wereinvestigated. Materials and Methods: 74 patients with relapsing-remitting multiple sclerosis who were in the remission periodwere included in the study. The control group consisted of 50 healthy individuals with similar age and gender.Serum vitamin D, parathormone, interleukin-10 and tumor necrosis factor-α levels were tested in the patient andcontrol groups. The relationship of vitamin D with gender, clinical features and cytokine levels was alsoinvestigated.Results: The mean vitamin D level was 14.4 ng/ml in the patient group and 16 ng/ml in the control group. Thelevels of vitamin D (p: 0,206), Interleukin-10 (p: 0,081), Tumor necrosis factor-α (p: 0,340) and parathormone (p:0,107) were similar in the patient and control groups. Although vitamin D values tended to decrease as clinicalseverity was worsening, this relationship was not statistically significant. Vitamin D levels found to be lower infemale .Conclusion: Vitamin D levels were low in both the patient and control group. There was no correlation betweenvitamin D levels and clinical features.

Özet

Giriş: Güneş ışığına maruziyetin fazla olduğu bölgelerde Multipl Skleroz’un daha az sıklıkla görülmesinde D vitamininin rolü olduğu düşünülmektedir. Vitamin D’nin klinik özellikler ile ilişkisi ve bu etkisinin kadın hastalarda daha belirgin olduğu görüşü tartışmalıdır. Bu çalışmada relapsing-remitting multipl skleroz hastalarında vitamin D, sitokin ve cinsiyet arasındaki ilişki araştırıldı. Gereç ve yöntem: Çalışmaya remisyon döneminde olan 74 Relapsing-remitting multiple skleroz hastası alındı. Kontrol grubu benzer yaş ve cinsiyette 50 sağlıklı bireyden oluşturuldu. Hasta ve kontrol gruplarında serum vitamin D, interlökin-10, tümör nekroz faktör-α ve parathormon düzeyleri ölçüldü. Vitamin D’nin cinsiyet ve klinik özellikler ile ilişkisi araştırıldı. Bulgular: Ortalama vitamin D düzeyi hasta grubunda 14.4 ng/ml, kontrol grubunda 16 ng/ml olarak saptandı. Hasta ve kontrol gruplarında vitamin D (p:0.206), Interlökin-10 (p:0.081), tümör nekroz faktör-α (p: 0,340) ve parathormon (p:0.107) düzeyleri benzer bulundu. Klinik ağırlaştıkça vitamin D düzeyinin düşme eğiliminde olduğu gözlendi ise de bu ilişki istatistiksel anlamlılığa ulaşmadı. Kadınlarda vitamin D düzeyi daha düşük saptandı. Sonuç: Hem hasta hem de kontrol grubunda vitamin D düzeyi düşüktü ve vitamin D klinik özellikler ile ilişkili bulunmadı.

🔖

Cite This Article

ÇOLAK, A., ŞİRİNOCAK, P. B., EŞKUT, N., ŞENER, U., ZORLU, Y. (2022). VITAMIN D, PARATHORMONE, GENDER, INTERLEUKIN 10 AND TUMOR NECROSIS ALPHA RELATIONSHIP IN MULTIPLE SCLEROSIS PATIENTS. İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 24 - Sayı: 2, 121–126. https://ajindex.com/articles/557758

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Ascherio A, Munger KL, White R, Köchert K, Simon KC, Polman CH, et al. Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA Neurol 2014; 71(3): 306-14
  2. Mowry EM, Waubant E, Mc Culloch CE, Okuda DT, Evangelista AA, Lincoln RR et al. Vitamin D predicts new brain MRI activity in multiple sclerosis. Ann Neurol 2012; 72(2): 234-40 3. Pierrot-Deseilligny C, Souberbielle J. Vitamin D and multiple sclerosis: An update. Mult Scler Relat Disor 2017; 14: 35-45
  3. Runia TF, Hop WC, de Rijke YB, Buljevoc D, Hintzen RQ. Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis. Neurology 2012; 79(3): 261-6
  4. Sintzel MB, Rametta M, Reder AT. Vitamin D and multiple sclerosis: A comprehensive review. Neurol Ther 2018; 7: 59-85 6. Sellner J, Kraus J, Awad A, Milo R, Henner B, Stüve O. The increasing incidence and prevalence of female multiple sclerosis – A critical analysis of potential environmental factors. Autoimmun Rev 2011; 10(8): 495-502
  5. Eskandari G, Ghajarzadeh M, Yekaninejad MS, Sahraian MA, Gorji R, Rajaei F, et al. Comparison of serum vitamin D level in multiple sclerosis patients, their siblings, and healthy controls. Iran J Neurol 2015; 14(2): 81-5
  6. Gelfand JM, Cree BA, McElroy J, Okseberg J, Green R, Mowry EM, et al. Vitamin D in African Americans with multiple sclerosis. Neurology 2011; 76(21): 1824-30
  7. Karampoor S, Zahednasab H, Ramagopalan S, Mehrpour M, Safornejad Tameshkel F, et al. 25-hydroxyvitamin D levels are associated with multiple sclerosis in Iran: A cross-sectional study. J Neuroimmunol 2016; 290; 47-8
  8. Kumar RS, Syed S, Kumar AA, Kumari KNS, Sajitha K. Serum vitamin D levels in Indian patients with multiple sclerosis. Ind J Clin Biochem 2013; 28(3): 255-8
  9. Wawrzyniak S, Mikolajewska E, Kuczko-Piekarska E, Niezgozinska-Maciejek A, Goch A. Association of vitamin D status and clinical and radiological outcomes in a treated MS population in Poland. Brain Behav 2017;7(2):e00609
  10. Zhang Y, Liu G, Han X, Dong H, Geng J. The association of serum 25-hydroxyvitamin D levels with multiple sclerosis severity and progression in a case-control study from China. J Neuroimmunol 2016; 297: 127-31
  11. Hussain AN, Alkhenizan AH, El Shaker M, Raef H, Gabr A. Increasing trends and significance of hipovitaminosis D: a population-based study in Kingdom of Saudi Arabia. Arch Osteoporos 2014; 9: 2-5 14. Holick MF. High prevalance of vitamin D inadequacy and implications for